Abeona Therapeutics Inc.
ABEO
$6.89
$0.030.44%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 208.83% | 42.36% | -17.62% | -58.84% | -33.79% |
| Total Depreciation and Amortization | 6.94% | -1.19% | -9.10% | -18.19% | -24.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3,085.33% | -137.63% | -41.69% | 203.22% | 341.33% |
| Change in Net Operating Assets | 173.08% | -92.44% | -145.13% | 106.88% | 136.10% |
| Cash from Operations | -56.34% | -50.44% | -51.36% | -16.58% | 1.42% |
| Capital Expenditure | -250.16% | -272.55% | -638.97% | -488.40% | -447.65% |
| Sale of Property, Plant, and Equipment | -100.00% | -91.18% | -91.18% | -89.43% | -89.91% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 408.76% | -162.42% | -11,088.66% | -22.18% | -252.45% |
| Cash from Investing | 392.09% | -177.09% | -18,965.38% | -27.25% | -264.78% |
| Total Debt Issued | -100.00% | -100.00% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -79.43% | 96.34% | 129.02% | 21.45% | 106.93% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 59.28% | 58.39% | -348.49% | -12,276.92% | -14,500.00% |
| Cash from Financing | -82.81% | 36.75% | 181.02% | 46.90% | 141.87% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 357.82% | -112.60% | 3,370.31% | 282.93% | 616.41% |